Table 2.xls (5.5 kB)

Base-case cost-effectiveness analysis^*.

dataset

posted on 2021-03-11, 18:29 authored by Jane J. Kim, Kate T. Simms, James Killen, Megan A. Smith, Emily A. Burger, Stephen Sy, Catherine Regan, Karen Canfell

History

Usage metrics

Keywords

age 21 years vaccine efficacy cancer screening practice age 45 years noncervical HPV-related cancers United States HPV microsimulation models ICER age 26 years cost-effectiveness analysis Background future vaccination uptake age limit QALY 45 years HPV vaccination Human papillomavirus vaccination

Licence

CC BY 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

Base-case cost-effectiveness analysis*.

History

Usage metrics

Categories

Keywords

Licence

Exports

Base-case cost-effectiveness analysis^*.